A human Epstein-Barr virus (EBV)-positive lymphoblastoid B cell line, named BA-D10-4, produces a factor of a molecular mass less than 10 kDa that promotes cell proliferation of both BA-D10-4 cells and other human T or B lymphoid cell lines, either EBV-positive or -negative. The factor synergizes with higher molecular mass autocrine growth factors and makes both BA-D10-4 cells and B cell lines from Burkitt's lymphoma, but not cells from T cell leukemia, more responsive to interIeukin-1 and interleukin-6. Therefore, this low molecular mass factor seems to be an autocrine growth factor per se and to have the characteristics of a competence factor.
INTRODUCTION
Epstein-Barr virus (EBV) is associated with endemic Burkitt's lymphoma (BL) and nasopharyngeal carcinoma and seems to play a role in the pathogenesis of B cell lymphomas in patients with severe congenital or acquired immunodeficiency [1] .
EBV latently infects human B lymphocytes inducing lymphoblastoid cell transformation and immortalization; it has been suggested that EBV-transformed B cells may become independent of exogenous growth factors that normally control B cell proliferation, by acquiring the ability to synthesize and respond to autocrine, selfstimulating molecules. Although first described at the beginning of the 1980s, EBV-transformed B cell-derived autocrine growth factors are poorly understood; so far, they include two cytokines, i.e. interleukin 1 (IL-1) [2, 3] and IL-6 [4, 5] , the adult T cell leukemia-derived factor (ADF/thioredoxin), which is also produced by 450 human T-lymphotropic virus type I (HTLV-I)-infected T cells [6] , and a 25-kDa form of the CD23 molecule, a B cell activation membrane antigen, whose up-regulation would be activated by the EBNA-2 gene [7] [8] [9] .
Other growth factors produced by EBV-transformed B cells have been reported; these include a high molecular mass (60 kDa) factor produced by Namalwa cells [10] , a low molecular mass (16 kDa) factor, apparently also occurring in dimeric or tetrameric forms [11] , and a 12-kDa molecular form derived from the further cleavage of the 25-kDa fragment of CD23 [9] . More recently, an autocrine growth factor of less than 1.3 kDa has also been reported [4] .
In this paper we have studied a low molecular mass factor(s) secreted in culture supernatant by a human EBV-positive lymphoblastoid B cell line (BA-D10-4) established from the peripheral blood of a healthy donor, for the capacity of promoting cell growth of both BA-D10-4 cells and other human B or T lymphoid celt lines.
MATERIALS AND METHODS

Cells, cell lines and reagents
The human EBV-positive lymphoblastoid cell line BA-D10-4 was studied. BA-D10-4 is a cloned line producing human IgM monoclonal antibody to mycobacterial antigen which was established in our laboratory from the peripheral blood cells of a tuberculin skin test-positive healthy donor, according to a method described in detail elsewhere [12] . The activity of soluble factors produced by BA-D10-4 cells on different human and animal cells lines has recently been reported [13] .
Other human cell lines used in this study include: Raji, EBV-positive cells from BL; P3HR-1, EBV-positive cells from BL, containing a deletion in the EBNA-2-encoding region producer of non-transforming virus; Ramos, EBV-negative cells from BL; and Molt-4, cells from acute T lymphoblastic leukemia.
All the cell lines were routinely cultured in RPMI 1640, supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM Lglutamine, 100 U/ml penicillin, 100/zg/ml streptomycin, and 0.25 ~g/ml fungizone (ICN Laboratories, Milan, Italy). For both production and assay of BA-D10-4-derived autocrine growth factors, serum-free Iscove's medium, containing bovine serum albumin and human transferrin (ICN), was used.
Human recombinant interleukin-1/3 (rlL-1) and rIL-6 were purchased from Genzyme (Boston, MA).
Production of BA-DlO-4-derit'ed low molecular mass growth factors
BA-D10-4 cells, cultured in RPMI 1640 with 10% FBS to a density of 5 × 105/ml, were washed three times in serum-free medium and suspended at 1 × 10¢'/ml in lscove's medium. The cells were then incubated for 3 days at 37°C in a 5% CO 2 atmosphere, the culture supernatant was collected by centrifugation and ultrafiltrated by a tangential flow device (Minitan Ultrafiltration System, Millipore, USA) through a membrane with a M r 10000 cutoff (Minitan 10000 NMWL, Millipore), thus yielding a 10-fold concentrated supernatant and an ultrafiltrate fraction. Ultrafiltration procedures were controlled by high resolution fast protein liquid chromatography (FPLC).
Assay for BA-DlO-4-dericed autocrine growth factors
To assay the proliferative activity of either BA-D10-4-derived factors or recombinant interleukins, target ceils, cultured in RPMI 1640 supplemented with 10% FBS to a density of 2 × 105/ml, were extensively washed in serum-free medium and then suspended in Iscove's medium; 100/xl per well of target cell suspension containing 1 × 104 cells were plated in 96-well plates (Falcon); the cultures then received 100 /xl of control or test samples (see legend to Figures and Table 1 ). Unless otherwise stated, the microcultures were pulsed either immediately, after 1 day, or after 2 days at 37°C in 5% CO 2, with 0.5/zCi [3H]thymidine (~HTdR; 25 Ci/mmol) for the last 24 h of culture. The cells were then collected with a semiautomatic cell harvester (Nunc, Denmark) and counted for radioactivity in a Beckman liquid scintillation counter. Days of culture Days of culture 
Gel filtration chromatography
Samples (2 ml) were applied to a pre-equilibrated Superose 12 HR gel filtration preparative column (Pharmacia, Sweden) driven by a FPLC apparatus (Pharmacia). The column was eluted at room temperature with phosphatebuffered saline (PBS), pH 7.2, at a flow rate of 1 ml rain -~ and 1.5-mi fractions were collected. Molecular mass standards included BSA (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa) and RNase (13.7 kDa) (Pharmacia).
RESULTS
BA-D l O-4-derived autocrine growth factors
Autocrine growth factors secreted by BA-D10-4 cells were assayed in'conditioned culture supernatant and ultrafiltrate and their activity was compared to the growth-promoting activity of rIL-1 and rIL-6. As can be seen in Fig. 1A , both unfractionated crude supernatant and the ultrafiltrate induced a significant increase in DNA synthesis in BA-D10-4 target c~ lls at all tested times; the growth-promoting activity of the conditioned supernatant was higher than that obtained with rIL-1 and rIL-6 at any tested dose (Fig. 1B,  C) . Also, DNA synthesis in the presence of conditioned medium, ultrafiltrate or rIL-6 steadily increased starting from the first 24 h of incubation and was maximal at 48-72 h of incubation; while DNA synthesis in the presence of rIL-1 was maximal in the first 24 h of incubation and decreased thereafter.
Gel filtration chromatography of BA-DIO-4-derived autocrine growth factors
A sample of 10-fold concentrated conditioned supernatant (2 ml) was applied to a pre-equilibrated Superose 12 HR gel filtration preparative column driven by a FPLC apparatus. The column was eluted at room temperature with PBS and the fractions, collected in the range of 100-10 kDa molecular mass, were tested for their capacity to induce DNA synthesis in BA-D10-4 cells, either in the absence or presence of the ultrafiltrated conditioned supernatant. As can be seen in Fig. 2 , when fractions were tested in the absence of the ultrafiltrate, four peaks of low DNA synthesis-promoting activity were found at approximately 40, 30, 20-18 and 15-13 kDa. However, when the fractions were assayed in the presence of the ultrafiltrate fraction, DNA synthesis of target cells was markedly higher and at least two major peaks, of approx. 50-35 kDa and 30-18 kDa, and two minor peaks, of approx. 67 and 15-13 kDa, were found.
Combined effect of low molecular mass factor(s) and rlL-1 or rlL-6 on DNA synthesis of lymphoid cell lines
The combined effect on DNA synthesis of the ultrafiltrate fraction of BA-D10-4-conditioned supernatant and rIL-1 or rIL-6 was studied in BA-D10-4 cells and other human lymphoid cell lines. The tested cell lines included Raji, P3HR-1, and Ramos cells from Burkitt's lymphoma and Molt-4 cells from acute T lymphoblastic leukemia. As shown in Table 1 , the ultrafiltered BA-D10-4-conditioned supernatant, as well as rIL-1 and rIL-6, induced a significant increase in DNA synthesis in all lymphoid cell lines tested, either 
DISCUSSION
The data reported in this paper show that BA-D10-4 cells, i.e. B lymphocytes from a normal donor immortalized by EBV infection in vitro, produce and respond to autocrine growth factors, including a molecule with a molecular mass of less than 10 kDa. BA-D10-4 cells also respond to human IL-1 and IL-6, as expected [2] [3] [4] [5] , but DNA synthesis induced by these cytokines was generally lower than that obtained with crude conditioned supernatant. Furthermore, IL-1 increased DNA synthesis in the early phases of in vitro growth, while IL-6 steadily sustained cell proliferation.
Taken together, these findings indicate that multiple factors, likely acting in synergy, are needed to sustain the growth of EBV-infected cells. In fact, gel filtration analysis of concentrated conditioned supernatant, although not providing conclusive data, showed several peaks of autocrine growth factor activity, which was markedly enhanced by a factor(s) of less than 10 kDa which was present in the ultrafiltrate. Therefore, this factor seems to be an autocrine growth factor per se in that it promotes proliferation of BA-D10-4 cells, and to have the characteristics of a 'competence factor' [14, 15] , in that it induces a state of heightened sensitivity to other growth factors in target cells. The synergism of a soluble factor from virus-infected human lymphocytes with other cytokines has been recently reported in the case of adult T cell leukemia-derived factor (ADF/thioredoxin), a molecule of 13 kDa, produced by both human T-lymphotropic virus type I (HTLV-I)-infected T cells and EBV-transformed B lymphocytes, that acts as an autocrine growth factor and synergizes with IL-1 and IL-2, possibly by up-regulating IL-2 receptor expression [6] .
The growth-promoting activity of the low molecular mass factor(s) reported herein is not restricted to BA-D10-4 cells, since it also promotes cell proliferation of human cell lines from both Burkitt's lymphoma, either EBV-positive or -negative, and from acute T cell leukemia. BL lines, however, seem more responsive to this factor than to IL-1 or IL-6, while leukemia T cells respond better to IL-1 or IL-6. It is of interest that the combined activity of BA-D10-4-derived low molecular mass factor and IL-1 or IL-6 resulted in a further increase in DNA synthesis on B cell lines but not on leukemia T cells, thus suggesting that the 'competence factor' activity is B cell-specific.
There is as yet little information on the nature and role of autocrine growth factors, and even less on the 'competence factors', involved in the initiation and progression of EBV-positive B cell lymphomas [16] . It could be speculated that if the different factors involved in the autocrine growth could be identified, it might be possible to interrupt the autocrine loop. In fact, it has been shown in some cases that antibodies to growth factors can almost completely prevent the in vitro growth of autocrine stimulated cells [17] . In a different approach, it has also been shown that other cytokines, such as interferon-a, can downregulate the expression of autocrine growth factors, which might also be therapeutically valuable [181.
In conclusion, the identification of the exact interplay between the different growth factors produced by EBV-transformed B cells could turn out to be useful not only for a better understanding of EBV-induced B cell transformation, but also for a possible control of EBV-related malignancies.
